The commentary on the study: The efficacy of alicumab in patients with hypercholesterolaemia, depending on the type and dose of co-administered statin - a combined analysis of 8 clinical trials
2017
Abstract
Professor Catapano, an active chair of the European Society for Atherosclerosis, has recently published an important work with his team on the evaluation of the clinical efficacy of concurrent use of statins and propotain convertase inhibitors subtilisin/kexin-type inhibitors in the treatment of hypercholesterolaemia.